- Intercept Pharmaceuticals (NASDAQ:ICPT): Q4 EPS of -$0.64 beats by $0.06.
- Revenue of $405K (flat Y/Y) misses by $485K.
- Says it expects to be able to fund operations into Q3 2015 based upon currently expected level of program commitment and expected operating expenditures.
- Shares -13.6% AH.
- Press release
Intercept Pharmaceuticals EPS beats by $0.06, misses on revenue
Recommended For You
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ICPT | - | - |
| Intercept Pharmaceuticals, Inc. | ||